Portfolio comparison
University of Texas System vs Morphosys
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Texas System
Patents indexed
1
Year range
2022
Most recent
2022
biotechpharmaceutical
Top Patents1 enriched
US RE49280· 2022
A Custom-Built Protein to Block TGF-beta Signaling in Disease
Activity by Decade
2020s1
Company B
Morphosys
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticaldiagnosticshealthcare
Top Patents1 enriched
US 12590172· 2026
How to Find Antibodies That Only Detect Bound Drug Targets
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.